Andrew D. Dickinson - Jun 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Stock symbol
GILD
Transactions as of
Jun 10, 2022
Transactions value $
-$119,597
Form type
4
Date filed
6/13/2022, 08:13 PM
Previous filing
Mar 15, 2022
Next filing
Sep 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.65K +5.67% 68K Jun 10, 2022 Direct F1
transaction GILD Common Stock Options Exercise +1.03K +1.51% 69K Jun 10, 2022 Direct F1
transaction GILD Common Stock Tax liability -$120K -1.97K -2.85% $60.74 67.1K Jun 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.65K -6.86% 49.5K Jun 10, 2022 Common Stock 3.65K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -1.03K -2.07% 48.5K Jun 10, 2022 Common Stock 1.03K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.